Navigation Links
Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature

Consumers Oppose Prescription Mandate; Prefer Alternative Method to Fighting Meth

JACKSON, Miss., Jan. 30 /PRNewswire-USNewswire/ -- Mississippians are expressing outrage at lawmakers' rush to change over-the-counter cold and allergy medicines containing pseudoephedrine (PSE) to a prescription (Rx) drug.

"The Consumer Healthcare Products Association (CHPA) has provided a phone number for Mississippians to contact their legislators which within the first day fielded scores of calls from around the state. We have heard their outrage on talk radio, and online posting to news web pages. And recent polling shows almost two-thirds of Mississippi voters oppose the legislation. Everyone wants to fight meth, but Mississippians believe an electronic tracking procedure is better than the added cost and burden of a prescription mandate," said Elizabeth Funderburk of CHPA.

CHPA's legislative call line for Mississippians is 1-866-346-8118 or they can visit

Almost two-thirds of Mississippi voters surveyed oppose making common cold and allergy medications containing PSE available by Rx-only, and 74 percent agree that an Rx-only requirement would create an "unnecessary burden" for law-abiding citizens (2010, DB Research). While those voters were not heard or even considered before last week's rushed House vote, Mississippians are now making their voices heard and contacting their state Senators.

Last week, the state's House passed H.B. 512, legislation that would impose an Rx-only mandate on commonly available cold and allergy medications containing PSE, without a hearing and are now trying to push identical legislation through the Senate (S.B. 2339). Should this legislation pass, it would place an unnecessary burden on families, significantly increase consumer costs, and hurt the state's finances at the worst possible time.

"Because Mississippi does not tax prescription drugs, this legislation would also divert $590,000 from the general fund annually, as well as increase the costs to Mississippi's Medicaid program through increased doctor's visits and prescriptions as a result," Funderburk continued. "This would be an expensive new mandate from the state on the budgets of Mississippi families and Mississippi taxpayers. There is a better way to fight meth, and that's through establishing an electronic tracking program to stop the illegal sale to criminals."

The proposed prescription legislation flies in the face of Mississippi voter sentiment. Sixty-one percent of Mississippi voters surveyed are opposed to an Rx-only law. And 59 percent indicate they feel the legislative train is speeding forward too fast, agreeing: "Before my state's lawmakers enact a new law, they should study the economic impact and societal burden a prescription law would pose."

What the lawmakers don't want the public to realize is that they are rejecting a better way to address the state's methamphetamine problem without limiting consumer access to these important medicines – a real-time electronic tracking (e-tracking) system of PSE purchases at the pharmacy or service counter. E-tracking is successfully being implemented across a growing number of states, including neighboring Louisiana in the near future. Two-thirds (66 percent) of those surveyed support such a system in Mississippi, as well.

The survey, conducted from January 14-23, involved 350 Mississippi state residents aged 18 or over, all of whom voted in the last election, and has a margin-of-error of +/-5.2%. The survey was sponsored by the Consumer Healthcare Products Association.

David Binder Research has been a source for innovative research for more than 25 years, providing high-quality survey, focus group and media research services to clients throughout the United States.

CHPA is the 129-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.  

SOURCE Consumer Healthcare Products Association



SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
2. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
3. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
4. VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests
5. St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels
6. New Studies End Debate on Embryonic Stem Cell Research
7. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
8. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
9. Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate
10. AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
11. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
Post Your Comments:
(Date:11/26/2015)... Carolina , 26 november 2015 /PRNewswire/ ... (AAIPharma/CML) kondigt de geplande investering aan van ... van de laboratoria en het mondiale hoofdkantoor ... De uitbreiding zal resulteren in extra kantoorruimte ... voldaan aan de groeiende behoeften van de ...
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... According to an article published November 10th ... widely heralded as a breakthrough for performing hernia repairs. The article explains that the ... is that it can greatly reduce the pain that a patient might otherwise experience ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, ... from Bronx, N.Y. “I thought there had to be a convenient and comfortable way ... , The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. ...
Breaking Medicine News(10 mins):